It turned out that overexpression of miR-30a could markedly inhibit invasive ability of PCa cells by dramatically decreasing the expressions of MMP-2 and MMP-9, whereas miR-30a inhibitor had the opposing effect on expressions of EMT markers. The gene discussed is MMP9; the disease is posterior cortical atrophy.